Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of PAP Treatment on Glycemic Control in Patients With Type 2 Diabetes and Obstructive Sleep Apnea

NCT00509223 is registered in ClinicalTrials.gov with ResMed as lead sponsor.

NCT NCT00509223
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00509223 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of PAP Treatment on Glycemic Control in Patients With Type 2 Diabetes and Obstructive Sleep Apnea
Lead sponsor
ResMed
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2007
Completion date
February 29, 2012
Enrollment
416 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus type 2